The right alzheimer 's drug could earn a drugmaker a lot of money .

那么一种奏效的阿尔茨海默氏药物能够使其制药商大发其财。

Glaxosmithkline , the u. k. 's largest drugmaker , fell 2.2 percent to 1263 pence .

英国最大的制药企业葛兰素史克公司股价下跌2.2%，至1263便士。

When one drugmaker has a manufacturing problem , others rarely step in .

当一家厂商出现了制作问题时其他厂家很少介入。

Chemical group dupont and the drugmaker merck both reported a drop in second quarter profits but their earnings exceeded wall street 's expectations .

化工集团杜邦和制药商默克的第二季度利润均有所下降，但两者的盈利均高出华尔街的预期。

Demattos said the drugmaker , which is developing other alzheimer 's drugs , is already engineering a human antibody that will target insoluble plaques .

据迪马托斯称，制药公司正在开发其他的治疗阿尔茨海默的药物，已经在制造针对不溶性斑块的人类抗体。